375 related articles for article (PubMed ID: 15569995)
1. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
[TBL] [Abstract][Full Text] [Related]
2. GEP associates with wild-type p53 in hepatocellular carcinoma.
Cheung ST; Wong SY; Lee YT; Fan ST
Oncol Rep; 2006 Jun; 15(6):1507-11. PubMed ID: 16685387
[TBL] [Abstract][Full Text] [Related]
3. The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.
Jones MB; Michener CM; Blanchette JO; Kuznetsov VA; Raffeld M; Serrero G; Emmert-Buck MR; Petricoin EF; Krizman DB; Liotta LA; Kohn EC
Clin Cancer Res; 2003 Jan; 9(1):44-51. PubMed ID: 12538450
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
[TBL] [Abstract][Full Text] [Related]
5. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
6. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
Park MY; Park YS; Nam JH
Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
[TBL] [Abstract][Full Text] [Related]
7. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Zhang P; Chan DW; Zhu Y; Li JJ; Ng IO; Wan D; Gu J
Clin Cancer Res; 2006 Nov; 12(22):6617-25. PubMed ID: 17121880
[TBL] [Abstract][Full Text] [Related]
8. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465
[TBL] [Abstract][Full Text] [Related]
9. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
10. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
11. [Expression of CXCR3 in hepatocellular carcinoma].
Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
[TBL] [Abstract][Full Text] [Related]
12. The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer.
Jones MB; Houwink AP; Freeman BK; Greenwood TM; Lafky JM; Lingle WL; Berchuck A; Maxwell GL; Podratz KC; Maihle NJ
J Soc Gynecol Investig; 2006 May; 13(4):304-11. PubMed ID: 16697948
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.
Liu LX; Jiang HC; Liu ZH; Zhu AL; Zhang WH; Wu LF; Zhou J; Wang XQ; Wu M
Oncol Rep; 2003; 10(6):1771-5. PubMed ID: 14534694
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
15. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
16. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
17. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.
Ho JC; Ip YC; Cheung ST; Lee YT; Chan KF; Wong SY; Fan ST
Hepatology; 2008 May; 47(5):1524-32. PubMed ID: 18393387
[TBL] [Abstract][Full Text] [Related]
18. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.
Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M
Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534
[TBL] [Abstract][Full Text] [Related]
19. FUP1, a gene associated with hepatocellular carcinoma, stimulates NIH3T3 cell proliferation and tumor formation in nude mice.
Pan W; Zhang Q; Xi QS; Gan RB; Li TP
Biochem Biophys Res Commun; 2001 Sep; 286(5):1033-8. PubMed ID: 11527404
[TBL] [Abstract][Full Text] [Related]
20. Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression.
Lee TK; Poon RT; Yuen AP; Man K; Yang ZF; Guan XY; Fan ST
Clin Cancer Res; 2006 Sep; 12(17):5082-9. PubMed ID: 16951224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]